Bryan L. Roth, M.D., Ph.D.

Printer-friendly versionPrinter-friendly version
Bryan L. Roth, M.D., Ph.D.

JOINED THE SCIENTIFIC COUNCIL IN 2004

Distinguished Professor, Department of Pharmacology, School
of Medicine, and Division of Medicinal Chemistry and Natural
Products, School of Pharmacy
Michael Hooker Chair, Protein Therapeutics and Translational
Proteomics
Director, National Institute of Mental Health (NIMH)
Psychoactive Drug Screening Program
University of North Carolina School of Medicine

Dr. Roth and his colleagues are engaged in drug discovery and synthetic biology research. He directs the NIMH Psychoactive Drug Screening Program and the NIMH funded National Cooperative Drug Discovery Group (UNC-Duke-Pfizer). Dr. Roth studies particularly the structure and function of G-protein coupled receptors (GPCRs), a large and diverse family of proteins encompassing more than 1 percent of the genome. GPCRs couple to multiple intracellular signaling pathways, and currently more than 50 percent of approved medications target GPCRs. The ultimate goal of his research is to find ways to treat psychiatric disease using GPCR-based therapeutics.

Before joining UNC, Dr. Roth was with Case Western Reserve University School of Medicine.

NARSAD Grants: Young Investigator 1992, Independent Investigator 1998, Distinguished Investigator 2008